METHODS OF USING SNS-595 FOR TREATMENT OF CANCER SUBJECTS WITH REDUCED BRCA2 ACTIVITY

• 收藏
• 分享

专利权人:

Inc.;Sunesis Pharmaceuticals

发明人:

Hawtin, Rachael E.,Fox, Judith A.

申请号：

AU2015207901

公开号：

AU2015207901A1

申请日:

2015.07.30

申请国别(地区):

AU

年份:

2015

代理人:

摘要：

#$%^&*AU2015207901A120150820.pdf#####ABSTRACT Methods of using SNS-595 for treatment of a subject having cancer with BRCA2 mutation are described. In certain embodiments, the methods comprise administering a therapeutically effective amount of SNS-595 to a subject in need thereof.FIGURE 1 120 -Eg- VC 8 100 ~-3- VC8-B2 800 40 200 0 0.1 0.2 0.3 0.4 0.5 06 Doxorubicin (pM) 1/10

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/